NASDAQ:INKT

Mink Therapeutics Stock Forecast

etoro logo Buy INKT
*Your capital is at risk
$11.15
+0.1000 (+0.90%)
At Close: Jul 13, 2026
AI Analysis AI Analysis of INKT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add INKT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Monday for MiNK Therapeutics, Inc. stock after gaining 0.90%
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 07, 2026 Gain 4.99%

The MiNK Therapeutics, Inc. stock price gained 0.90% on the last trading day (Monday, 13th Jul 2026), rising from $11.05 to $11.15. During the last trading day the stock fluctuated 6.52% from a day low at $10.79 to a day high of $11.49. The price has fallen in 6 of the last 10 days and is down by -4.21% for this period. Volume fell on the last day by -8 thousand shares and in total, 10 thousand shares were bought and sold for approximately $110.55 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.23% during the next 3 months and, with a 90% probability hold a price between $9.47 and $12.17 at the end of this 3-month period.

INKT Signals & Forecast

There are few to no technical positive signals at the moment. The MiNK Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $11.15 and $11.71. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 03, 2026, and so far it has fallen -12.62%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for MiNK Therapeutics, Inc. stock

MiNK Therapeutics, Inc. finds support from accumulated volume at $10.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.703 between high and low, or 6.52%. For the last week the stock has had daily average volatility of 6.78%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INKT) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect MiNK Therapeutics, Inc. to open at $11.14, and during the day (based on 14 day Average True Range), to move between $10.78 and $11.52, which gives a possible trading interval of +/-$0.740 (+/-6.86%) up or down from last closing price. If MiNK Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.95 (1.79%) than the resistance at $12.20 (9.42%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MiNK Therapeutics, Inc. stock A Buy?

MiNK Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.898 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $11.14 ( 0.0798%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

INKT Performance

Trading levels for INKT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 11.84 6.23%
R2 11.58 3.82%
R1 11.41 2.33%
Price 11.15
S1 10.87 -2.49%
S2 10.71 -3.98%
S3 10.44 -6.39%

Accumulated Volume Support & Resistance Levels

Level Price
R3 13.51 21.17%
R2 12.34 10.63%
R1 12.20 9.42%
Price 11.15
S1 10.95 -1.79%
S2 10.72 -3.86%
S3 10.51 -5.74%

FAQ

What is the symbol for MiNK Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for MiNK Therapeutics, Inc. is INKT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MiNK Therapeutics, Inc. Stock?
MiNK Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy MiNK Therapeutics, Inc. Stock?
MiNK Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MiNK Therapeutics, Inc. Stock.

What's the current price of MiNK Therapeutics, Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an MiNK Therapeutics, Inc. (INKT) share was $11.15.

What is the 52-week high and low for MiNK Therapeutics, Inc. Stock?
The 52-week high for MiNK Therapeutics, Inc. Stock is $51.89 and the 52-week low is $8.48.

What is the market capitalization of MiNK Therapeutics, Inc. Stock?
As of the Jul 13, 2026, the market capitalization of MiNK Therapeutics, Inc. is 55.548M.

When is the next earnings date for MiNK Therapeutics, Inc.?
The upcoming earnings date for MiNK Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT MINK THERAPEUTICS, INC.
MiNK Therapeutics
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was former...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE